Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight | Zendy

Jianzhou Yang | Zendy; Rihua Xie | Zendy; Daniel Krewski | Zendy; Yongjin Wang | Zendy; Mark Walker | Zendy; Shi Wu Wen | Zendy

Open Access

Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight

Author(s) -

Jianzhou Yang,

Rihua Xie,

Daniel Krewski,

Yongjin Wang,

Mark Walker,

Shi Wu Wen

Publication year - 2011

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2011.01.007

Subject(s) - trimethoprim , medicine , low birth weight , sulfamethoxazole , obstetrics , pregnancy , microbiology and biotechnology , antibiotics , biology , genetics

To examine the association between trimethoprim/sulfamethoxazole, other US Food and Drug Administration (FDA) C and D anti-infectives, and non anti-infective FDA C, D, and X drugs used during pregnancy with preterm birth and low birth weight.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research